Options
Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients
Journal
Anticancer Research
Journal Volume
43
Journal Issue
3
Start Page
1377-1384
ISSN
0250-7005
1791-7530
Date Issued
2023-02-28
Author(s)
YEN-HAO CHEN
YEN-YANG CHEN
JING-HOUNG WANG
CHAO-HUNG HUNG
SDGs
Publisher
International Institute of Anticancer Research
Type
journal-article